n-(2-chloroethyl)-n-nitrosoacetamide and Astrocytoma, Grade IV

n-(2-chloroethyl)-n-nitrosoacetamide has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bataille, B; Blanc, JL; Chantereau, T; Guilhot, J; Karayan-Tapon, L; Kusy, S; Lapierre, F; Larsen, CJ; Wager, M	1

Trials

1 trial(s) available for n-(2-chloroethyl)-n-nitrosoacetamide and Astrocytoma, Grade IV

Article	Year
Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas. Journal of neuro-oncology, 2004, Volume: 68, Issue:3 Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; DNA Methylation; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Middle Aged; Nitroso Compounds; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Promoter Regions, Genetic; Treatment Outcome	2004

Article

Year

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas.

Journal of neuro-oncology, 2004, Volume: 68, Issue:3

Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; DNA Methylation; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Middle Aged; Nitroso Compounds; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Promoter Regions, Genetic; Treatment Outcome

2004